SHANGPHARMA
ShangPharma is a China-based outsourcing partner in pharmaceutical and biotechnology research and development, who provides customized services to international pharmaceutical, biotech, agrochemical and chemical companies. As the holding company of Shanghai ChemPartner Co., Ltd., Shanghai ChemExplorer Company Ltd., China Gateway Pharmaceutical (Shanghai) Ltd. and China Gateway Pharma Products (Chengdu) Ltd., ShangPharma offers global pharmaceutical, biotechnology and chemical companies comprehen... sive services and materials for their research and development needs. ShangPharma currently has a team of more than 1,800 professionals, and more than 60% of the employees have post graduate educational experience of Master or Ph.D. degrees. ShangPharma has established comprehensive R&D partnerships with world-class academic institutes, universities as well as healthcare industry and organizations, to contribute more added-value for its clients' success.
SHANGPHARMA
Social Links:
Industry:
Biotechnology Health Care
Founded:
2002-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.shangpharma.com
Total Employee:
5001+
Status:
Closed
Contact:
86 21 5132 0088
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving IPv6 Shockwave Flash Embed Akamai Hosted China Telecom
Current Advisors List
Current Employees Featured
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-03-17 | Circle Pharma | ShangPharma investment in Series B - Circle Pharma | 45 M USD |
| 2018-09-25 | Morphic Therapeutic | ShangPharma investment in Series B - Morphic Therapeutic | 80 M USD |
| 2018-01-16 | APRINOIA Therapeutics | ShangPharma investment in Series B - APRINOIA Therapeutics | 11.1 M USD |
| 2017-12-06 | Obsidian Therapeutics | ShangPharma investment in Series A - Obsidian Therapeutics | 49.5 M USD |
| 2016-12-21 | Circle Pharma | ShangPharma investment in Series A - Circle Pharma | 4.5 M USD |
| 2016-06-30 | Morphic Therapeutic | ShangPharma investment in Series A - Morphic Therapeutic | 51.5 M USD |
